Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) Sees Large Growth in Short Interest

Bellevue Life Sciences Acquisition Corp. (NASDAQ:BLAC) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 1,500 shares, an increase of 7.1% from the March 15th total of 1,400 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average trading volume of 22,000 shares, the days-to-cover ratio is currently 0.1 days.

Bellevue Life Sciences Acquisition Price Performance

Shares of Bellevue Life Sciences Acquisition stock opened at $10.69 on Thursday. The firm has a 50-day moving average of $10.64 and a 200-day moving average of $10.54. Bellevue Life Sciences Acquisition has a 52-week low of $10.11 and a 52-week high of $11.16.

Institutional Investors Weigh In On Bellevue Life Sciences Acquisition

A number of institutional investors have recently modified their holdings of BLAC. UBS Group AG bought a new stake in shares of Bellevue Life Sciences Acquisition in the first quarter valued at about $82,000. Condor Capital Management bought a new stake in shares of Bellevue Life Sciences Acquisition in the fourth quarter valued at about $121,000. Cowen AND Company LLC bought a new stake in shares of Bellevue Life Sciences Acquisition in the fourth quarter valued at about $165,000. Wealthspring Capital LLC bought a new stake in shares of Bellevue Life Sciences Acquisition in the third quarter valued at about $209,000. Finally, Toroso Investments LLC bought a new stake in Bellevue Life Sciences Acquisition during the third quarter worth about $313,000. Institutional investors own 55.30% of the company’s stock.

Bellevue Life Sciences Acquisition Company Profile

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the healthcare industry. Bellevue Life Sciences Acquisition Corp.